Skip to main content
NCBI home page
Nucleic Acids Research logoLink to Nucleic Acids Research
. 1997 Dec 15;25(24):5010–5016. doi: 10.1093/nar/25.24.5010

A rapid in vitro method for obtaining RNA accessibility patterns for complementary DNA probes: correlation with an intracellular pattern and known RNA structures.

O Matveeva 1, B Felden 1, S Audlin 1, R F Gesteland 1, J F Atkins 1
PMCID: PMC147128  PMID: 9396809

Abstract

A technique is described to identify the rare sequences within an RNA molecule that are available for efficient interaction with complementary DNA probes: the target RNA is digested by RNase H in the presence of a random pool of complementary DNA fragments generated from the same DNA preparation that was used for target RNA synthesis. The DNA region was amplified by PCR, partially digested with DNase and denatured prior to RNA binding. In the presence of single-stranded DNA fragments the RNA was digested with RNase H such that, on average, each molecule was cut once. Cleavage sites were detected by gel electrophoresis either directly with end-labeled RNA or by primer extension. The pattern of accessible sites on c- raf mRNA was determined and compared with the known profile of activity of oligonucleotides found in cells, showing the merit of the method for predicting oligonucleotides which are efficient for in vivo antisense targeting. New susceptible sites in the 3'-untranslated region of c- raf mRNA were identified. Also, four RNAs were probed to ascertain to what extent structure predicts accessibility: the P4-P6 domain of the Tetrahymena group I intron, yeast tRNAAsp, Escherichia coli tmRNA and a part of rat 18S rRNA.

Full Text

The Full Text of this article is available as a PDF (486.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alahari S. K., Dean N. M., Fisher M. H., Delong R., Manoharan M., Tivel K. L., Juliano R. L. Inhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotides. Mol Pharmacol. 1996 Oct;50(4):808–819. [PubMed] [Google Scholar]
  2. Birikh K. R., Berlin Y. A., Soreq H., Eckstein F. Probing accessible sites for ribozymes on human acetylcholinesterase RNA. RNA. 1997 Apr;3(4):429–437. [PMC free article] [PubMed] [Google Scholar]
  3. Bonner T. I., Oppermann H., Seeburg P., Kerby S. B., Gunnell M. A., Young A. C., Rapp U. R. The complete coding sequence of the human raf oncogene and the corresponding structure of the c-raf-1 gene. Nucleic Acids Res. 1986 Jan 24;14(2):1009–1015. doi: 10.1093/nar/14.2.1009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bruice T. W., Lima W. F. Control of complexity constraints on combinatorial screening for preferred oligonucleotide hybridization sites on structured RNA. Biochemistry. 1997 Apr 22;36(16):5004–5019. doi: 10.1021/bi9620767. [DOI] [PubMed] [Google Scholar]
  5. Campbell T. B., Cech T. R. Identification of ribozymes within a ribozyme library that efficiently cleave a long substrate RNA. RNA. 1995 Aug;1(6):598–609. [PMC free article] [PubMed] [Google Scholar]
  6. Cate J. H., Gooding A. R., Podell E., Zhou K., Golden B. L., Kundrot C. E., Cech T. R., Doudna J. A. Crystal structure of a group I ribozyme domain: principles of RNA packing. Science. 1996 Sep 20;273(5282):1678–1685. doi: 10.1126/science.273.5282.1678. [DOI] [PubMed] [Google Scholar]
  7. Chen T. Z., Lin S. B., Wu J. C., Choo K. B., Au L. C. A method for screening antisense oligodeoxyribonucleotides effective for mRNA translation-arrest. J Biochem. 1996 Feb;119(2):252–255. doi: 10.1093/oxfordjournals.jbchem.a021231. [DOI] [PubMed] [Google Scholar]
  8. Dagle J. M., Weeks D. L., Walder J. A. Pathways of degradation and mechanism of action of antisense oligonucleotides in Xenopus laevis embryos. Antisense Res Dev. 1991 Spring;1(1):11–20. doi: 10.1089/ard.1991.1.11. [DOI] [PubMed] [Google Scholar]
  9. Dean N. M., McKay R., Condon T. P., Bennett C. F. Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters. J Biol Chem. 1994 Jun 10;269(23):16416–16424. [PubMed] [Google Scholar]
  10. England T. E., Uhlenbeck O. C. Enzymatic oligoribonucleotide synthesis with T4 RNA ligase. Biochemistry. 1978 May 30;17(11):2069–2076. doi: 10.1021/bi00604a008. [DOI] [PubMed] [Google Scholar]
  11. Felden B., Himeno H., Muto A., Atkins J. F., Gesteland R. F. Structural organization of Escherichia coli tmRNA. Biochimie. 1996;78(11-12):979–983. doi: 10.1016/s0300-9084(97)86720-x. [DOI] [PubMed] [Google Scholar]
  12. Felden B., Himeno H., Muto A., McCutcheon J. P., Atkins J. F., Gesteland R. F. Probing the structure of the Escherichia coli 10Sa RNA (tmRNA). RNA. 1997 Jan;3(1):89–103. [PMC free article] [PubMed] [Google Scholar]
  13. Giles R. V., Tidd D. M. Increased specificity for antisense oligodeoxynucleotide targeting of RNA cleavage by RNase H using chimeric methylphosphonodiester/phosphodiester structures. Nucleic Acids Res. 1992 Feb 25;20(4):763–770. doi: 10.1093/nar/20.4.763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gutell R. R., Power A., Hertz G. Z., Putz E. J., Stormo G. D. Identifying constraints on the higher-order structure of RNA: continued development and application of comparative sequence analysis methods. Nucleic Acids Res. 1992 Nov 11;20(21):5785–5795. doi: 10.1093/nar/20.21.5785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gutierrez A. J., Matteucci M. D., Grant D., Matsumura S., Wagner R. W., Froehler B. C. Antisense gene inhibition by C-5-substituted deoxyuridine-containing oligodeoxynucleotides. Biochemistry. 1997 Jan 28;36(4):743–748. doi: 10.1021/bi9620971. [DOI] [PubMed] [Google Scholar]
  16. Ho S. P., Britton D. H., Stone B. A., Behrens D. L., Leffet L. M., Hobbs F. W., Miller J. A., Trainor G. L. Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries. Nucleic Acids Res. 1996 May 15;24(10):1901–1907. doi: 10.1093/nar/24.10.1901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Holmberg L., Melander Y., Nygård O. Probing the conformational changes in 5.8S, 18S and 28S rRNA upon association of derived subunits into complete 80S ribosomes. Nucleic Acids Res. 1994 Jul 25;22(14):2776–2783. doi: 10.1093/nar/22.14.2776. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Laptev A. V., Lu Z., Colige A., Prockop D. J. Specific inhibition of expression of a human collagen gene (COL1A1) with modified antisense oligonucleotides. The most effective target sites are clustered in double-stranded regions of the predicted secondary structure for the mRNA. Biochemistry. 1994 Sep 13;33(36):11033–11039. doi: 10.1021/bi00202a024. [DOI] [PubMed] [Google Scholar]
  19. Lieber A., Strauss M. Selection of efficient cleavage sites in target RNAs by using a ribozyme expression library. Mol Cell Biol. 1995 Jan;15(1):540–551. doi: 10.1128/mcb.15.1.540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lima W. F., Brown-Driver V., Fox M., Hanecak R., Bruice T. W. Combinatorial screening and rational optimization for hybridization to folded hepatitis C virus RNA of oligonucleotides with biological antisense activity. J Biol Chem. 1997 Jan 3;272(1):626–638. [PubMed] [Google Scholar]
  21. Milner N., Mir K. U., Southern E. M. Selecting effective antisense reagents on combinatorial oligonucleotide arrays. Nat Biotechnol. 1997 Jun;15(6):537–541. doi: 10.1038/nbt0697-537. [DOI] [PubMed] [Google Scholar]
  22. Minshull J., Hunt T. The use of single-stranded DNA and RNase H to promote quantitative 'hybrid arrest of translation' of mRNA/DNA hybrids in reticulocyte lysate cell-free translations. Nucleic Acids Res. 1986 Aug 26;14(16):6433–6451. doi: 10.1093/nar/14.16.6433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Miraglia L., Geiger T., Bennett C. F., Dean N. M. Inhibition of interleukin-1 type I receptor expression in human cell-lines by an antisense phosphorothioate oligodeoxynucleotide. Int J Immunopharmacol. 1996 Apr;18(4):227–240. doi: 10.1016/0192-0561(96)84502-4. [DOI] [PubMed] [Google Scholar]
  24. Monia B. P., Johnston J. F., Geiger T., Muller M., Fabbro D. Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase. Nat Med. 1996 Jun;2(6):668–675. doi: 10.1038/nm0696-668. [DOI] [PubMed] [Google Scholar]
  25. Monia B. P., Lesnik E. A., Gonzalez C., Lima W. F., McGee D., Guinosso C. J., Kawasaki A. M., Cook P. D., Freier S. M. Evaluation of 2'-modified oligonucleotides containing 2'-deoxy gaps as antisense inhibitors of gene expression. J Biol Chem. 1993 Jul 5;268(19):14514–14522. [PubMed] [Google Scholar]
  26. Sczakiel G., Homann M., Rittner K. Computer-aided search for effective antisense RNA target sequences of the human immunodeficiency virus type 1. Antisense Res Dev. 1993 Spring;3(1):45–52. doi: 10.1089/ard.1993.3.45. [DOI] [PubMed] [Google Scholar]
  27. Silberklang M., Prochiantz A., Haenni A. L., Rajbhandary U. L. Studies on the sequence of the 3'-terminal region of turnip-yellow-mosaic-virus RNA. Eur J Biochem. 1977 Feb;72(3):465–478. doi: 10.1111/j.1432-1033.1977.tb11270.x. [DOI] [PubMed] [Google Scholar]
  28. Southern E. M., Case-Green S. C., Elder J. K., Johnson M., Mir K. U., Wang L., Williams J. C. Arrays of complementary oligonucleotides for analysing the hybridisation behaviour of nucleic acids. Nucleic Acids Res. 1994 Apr 25;22(8):1368–1373. doi: 10.1093/nar/22.8.1368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Stull R. A., Taylor L. A., Szoka F. C., Jr Predicting antisense oligonucleotide inhibitory efficacy: a computational approach using histograms and thermodynamic indices. Nucleic Acids Res. 1992 Jul 11;20(13):3501–3508. doi: 10.1093/nar/20.13.3501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Szoka F. C., Jr Many are probed, but few are chosen. Nat Biotechnol. 1997 Jun;15(6):509–509. doi: 10.1038/nbt0697-509. [DOI] [PubMed] [Google Scholar]
  31. Vaish N. K., Heaton P. A., Eckstein F. Isolation of hammerhead ribozymes with altered core sequences by in vitro selection. Biochemistry. 1997 May 27;36(21):6495–6501. doi: 10.1021/bi963134r. [DOI] [PubMed] [Google Scholar]
  32. Vickers T. A., Ecker D. J. Enhancement of ribosomal frameshifting by oligonucleotides targeted to the HIV gag-pol region. Nucleic Acids Res. 1992 Aug 11;20(15):3945–3953. doi: 10.1093/nar/20.15.3945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Westhof E., Dumas P., Moras D. Crystallographic refinement of yeast aspartic acid transfer RNA. J Mol Biol. 1985 Jul 5;184(1):119–145. doi: 10.1016/0022-2836(85)90048-8. [DOI] [PubMed] [Google Scholar]
  34. Williams K. P., Bartel D. P. Phylogenetic analysis of tmRNA secondary structure. RNA. 1996 Dec;2(12):1306–1310. [PMC free article] [PubMed] [Google Scholar]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES